5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, hydrochloride monohydrate

PK139950AUndetermined Publication Date: 2009-01-30SMITHKLINE BEECHAM PLC
0 Cites 0 Cited by

Patent Information

Application Number
PK200000341
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-30
Patent Text Reader

Abstract

The present invention relates to 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, hydrochloride monohydrate characterised in that it: (i) provides an infra red spectrum containing peaks at 3358, 2764, 1245, 833 and 760cm-1 ; and / or (ii) provides an X-ray powder diffraction (XRPD)pattern containing peaks at 15.0, 17.7, 23.0, 30.0 and 31.4 0 20; a pharmaceutical composition containing such a compound and the use of such a compound in medicine.
Need to check novelty before this filing date? Find Prior Art